#JPM22 - The gene edit­ing rev­o­lu­tion: Now it's time for hu­man da­ta to de­fine a fast-chang­ing field

John Car­roll:

Okay every­body, I’m John Car­roll. I’m the ed­i­tor of End­points News. I ap­pre­ci­ate the au­di­ence for join­ing us. I’m here with a great group of peo­ple to talk about prob­a­bly the most in­ter­est­ing thing that’s go­ing on in R&D right now with­in the whole bio­phar­ma in­dus­try. I think cer­tain­ly there’s been a tremen­dous amount of in­ter­est in it. There’s been a lot of in­ter­est in this par­tic­u­lar pan­el, I think be­cause of the peo­ple that we’ve got here for this one. I’m joined by David Liu from The Broad, Sekar Kathire­san, CEO of Verve, Patrick Hsu from Berke­ley and Nicole Gaudel­li, the gene edit­ing plat­form tech­nol­o­gy chief for Beam.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER